TYP 5.00% 2.1¢ tryptamine therapeutics limited

Ann: Exopharm LEAP Technology - Second Commercial Collaboration, page-12

  1. 922 Posts.
    lightbulb Created with Sketch. 129
    There will be more partnership/deal. Everybody wants to get in before Exo CD24 becomes a blockbuster drug.
    All IMHO of course
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.